This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Epam (EPAM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Epam (EPAM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CTSH or EPAM: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CTSH vs. EPAM: Which Stock Is the Better Value Option?
How to Boost Your Portfolio with Top Computer and Technology Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Will Epam (EPAM) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Epam (EPAM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CTSH vs. EPAM: Which Stock Is the Better Value Option?
by Zacks Equity Research
CTSH vs. EPAM: Which Stock Is the Better Value Option?
CTSH vs. EPAM: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CTSH vs. EPAM: Which Stock Is the Better Value Option?
CTSH or EPAM: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CTSH vs. EPAM: Which Stock Is the Better Value Option?
EPAM Systems Q1 Earnings and Revenues Beat Estimates, Stock Up
by Zacks Equity Research
EPAM's first-quarter results reflect growth across Financial Services, Software & Hi-Tech and Life Sciences and Emerging.
Compared to Estimates, Epam (EPAM) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Epam (EPAM) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Epam (EPAM) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Epam (EPAM) delivered earnings and revenue surprises of 6.17% and 1.37%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Seeking Clues to Epam (EPAM) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Epam (EPAM), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2025.
Analysts Estimate Epam (EPAM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Epam (EPAM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DAVA vs. EPAM: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
DAVA vs. EPAM: Which Stock Is the Better Value Option?
EPAM Q4 Earnings Beat Estimates: What's in Store for the Stock?
by Zacks Equity Research
EPAM's Q4 results reflect strength in the Financial Services, Software & Hi-Tech, Life Sciences and Emerging verticals, offset by Business Info and Travel & Consumer.
Epam (EPAM) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Epam (EPAM) delivered earnings and revenue surprises of 3.27% and 2.92%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Ahead of Epam (EPAM) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Epam (EPAM), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024.
Epam (EPAM) Reports Next Week: What to Expect
by Zacks Equity Research
Epam (EPAM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TASK vs. EPAM: Which Stock Is the Better Value Option?
by Zacks Equity Research
TASK vs. EPAM: Which Stock Is the Better Value Option?
Why Epam (EPAM) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Amdocs (DOX) Beats Q1 Earnings Estimates
by Zacks Equity Research
Amdocs (DOX) delivered earnings and revenue surprises of 1.22% and 0.34%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Roper Technologies (ROP) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Roper Technologies (ROP) delivered earnings and revenue surprises of 1.91% and 2.45%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Investors Should Buy EPAM Systems Stock Right Now
by Zacks Equity Research
EPAM is rapidly expanding in the emerging AI space through partnerships and acquisitions, making it a promising player for 2025 and beyond.
DXC or EPAM: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
DXC vs. EPAM: Which Stock Is the Better Value Option?
Zacks Industry Outlook ServiceNow, EPAM Systems and DXC Technology
by Zacks Equity Research
ServiceNow, EPAM Systems and DXC Technology have been highlighted in this Industry Outlook article.
3 IT Services Stocks Worth Betting on From a Prospering Industry
by Aniruddha Ganguly
The Zacks Computers - IT Services Industry participants like ServiceNow (NOW), EPAM Systems (EPAM) and DXC Technology (DXC) are benefiting from ongoing digitization, strong demand for hybrid working solutions and improving IT spending.